Neuroblox, Inc. Company Profile, Contacts & Intelligence

Neuroblox, Inc. Overview

Existing biotech pipelines start with a target and hope for the desired clinical outcome. That might work for some indications, but not the brain. Psychiatric and neurological symptoms appear as changes in cognition, mood, and behavior. Clinical efficacy relies on regulating the neural control circuits behind them. When models can’t output cognition, mood, and behavior, they can’t evaluate the success of CNS interventions. That’s why 73% of drugs fail in Phase II, where efficacy is first measured. At Neuroblox we’ve spent the last 4 years building a platform that changes this paradigm: a multiscale, mechanistic neural circuit simulation engine that elicits cognition, mood and behavior, allowing scientists and clinicians to test brain interventions in silico. Neuroblox provides the ability to design neurotherapeutic interventions intentionally, with an outcomes-first approach. Load your model, simulate as many interventions as needed, compare and refine, and select the approach that works best. Thrilled to announce that our beta version is live. If you’d like to learn more or see a demo, feel free to message me directly, or reach out to info@neuroblox.ai https://www.neuroblox.ai/

Headquarters

Cambridge, Massachusetts, United States

Website

www.neuroblox.ai

Industry

Software Development

NAICS

Software Publishers

Neuroblox, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Neuroblox, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Neuroblox, Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Neuroblox, Inc.

Explore companies in related markets and compare their industry and employee estimates.